Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Squamous Cell of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04548440
What this trial is testing

Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-Sen University Cancer Center 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05078047
What this trial is testing

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Who this might be right for
Lung Cancer MetastaticRenal Cell CarcinomaHead and Neck Cancer+12 more
UNICANCER 646
Testing effectiveness (Phase 2)Study completedNCT03330249
What this trial is testing

Comparison of Two Concomitant Administration of RT With Cisplatin in Standard Infusion or Fractional Infusion

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Groupe Oncologie Radiotherapie Tete et Cou 124
Not applicableEnded earlyNCT03720158
What this trial is testing

Enteral Omega 3 During Radiotherapy to Improve the Quality of Life and Functionality of Head and Neck Cancer Patients

Who this might be right for
Head and Neck Squamous Cell CarcinomaQuality of LifeRadiotherapy; Complications
Coordinación de Investigación en Salud, Mexico 9
Testing effectiveness (Phase 2)UnknownNCT04650633
What this trial is testing

SHR-1701 in Patients With Recurrent/Metastatic Scchn

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Jiangsu HengRui Medicine Co., Ltd. 130
Early research (Phase 1)WithdrawnNCT05393635
What this trial is testing

ITIL-168 in Advanced Solid Tumors

Who this might be right for
Cervical CancerHead and Neck Squamous Cell CarcinomaNon-small Cell Lung Cancer
Instil Bio
Testing effectiveness (Phase 2)Looking for participantsNCT05985655
What this trial is testing

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Pancreatic AdenocarcinomaNon-small Cell Lung Cancer (NSCLC)+3 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 230
Testing effectiveness (Phase 2)Study completedNCT01437449
What this trial is testing

Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Who this might be right for
Head and Neck Cancer
Stanford University 27
Testing effectiveness (Phase 2)Study completedNCT00268671
What this trial is testing

Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN)

Who this might be right for
Head and Neck Neoplasms
Sanofi 45
Early research (Phase 1)Ended earlyNCT00906360
What this trial is testing

Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+29 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT02643550
What this trial is testing

Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Neoplasms
Innate Pharma 143
Testing effectiveness (Phase 2)Looking for participantsNCT07290010
What this trial is testing

The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Hebei Medical University Fourth Hospital 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04946968
What this trial is testing

Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers

Who this might be right for
Advanced Solid TumoursNon-small Cell Lung CancerHead and Neck Squamous Cell Carcinoma
National Cancer Centre, Singapore 24
Testing effectiveness (Phase 2)Ended earlyNCT00002735
What this trial is testing

SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 68
Testing effectiveness (Phase 2)WithdrawnNCT00934518
What this trial is testing

Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Cancer of the Head and Neck
Milton S. Hershey Medical Center
Testing effectiveness (Phase 2)UnknownNCT04215471
What this trial is testing

NeoAdjuvant Therapy With Immunoreagent (SHR-1316) for Resectable Oesophageal Squamous Cell carciNoma

Who this might be right for
Oesophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 30
Not applicableStudy completedNCT07199712
What this trial is testing

Ozone Therapy for Oral Mucositis in Patients Receiving Head and Neck Cancer Radio- and Chemotherapy

Who this might be right for
Oral MucositisOral StomatitisHead and Neck Cancer Squamous Cell Carcinoma+2 more
University of Pavia 58
Very early researchStudy completedNCT03238365
What this trial is testing

Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Lip, Oral Cavity and PharynxLarynx
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 50
Testing effectiveness (Phase 2)Looking for participantsNCT04671667
What this trial is testing

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+2 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT00898664
What this trial is testing

DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 74
Next Page
188